Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reneo Capital Management is a private investment management firm and hedge fund manager focused on the healthcare, pharmaceuticals, and life science sectors. Based in New York, the firm appears to operate as a long/short equity and investment advisory business rather than as a drug developer, healthcare services operator, or therapeutics company. Publicly available profiles indicate it has invested in biotech companies such as Erasca, but there is no evidence that Reneo Capital Management itself develops pharmaceutical products or maintains an internal therapeutic pipeline. For biotech diligence purposes, it is best classified as a healthcare-focused financial sponsor/investor rather than a life sciences operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reneo Capital Management.